Pricing Log in Create free account

Neumora Therapeutics, Inc. (NMRA) vs OnKure Therapeutics, Inc. (OKUR)

Neumora Therapeutics, Inc. and OnKure Therapeutics, Inc. are both Biotechnology companies. OnKure Therapeutics, Inc. is the larger, with a market value of $102.3M against $91.5M — 1.1× the size. Across the 9 metrics below, OnKure Therapeutics, Inc. leads on 8 and Neumora Therapeutics, Inc. on 1.

Valuation

Metric NMRA OKUR Biotechnology median
P/E n/m n/m 10.26
P/S n/m n/m 9.18
P/B 2.08 0.73 2.05
Price to free cash flow n/m n/m 24.81
EV/EBITDA n/m 0.82 0.65
EV/Sales n/m n/m 8.98
Earnings yield (246.00%) (138.34%) (34.89%)
Free cash flow yield (194.76%) (37.94%) (24.52%)

Profitability

Metric NMRA OKUR Biotechnology median
Gross margin 0.00% 0.00% 65.16%
Operating margin 0.00% 0.00% 0.00%
Net margin 0.00% 0.00% 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity (187.11%) (46.91%) (50.12%)
Return on assets (121.89%) (44.24%) (45.60%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric NMRA OKUR Biotechnology median
Revenue growth (TTM) — — 6.26%
EPS growth (last fiscal year) 5.23% 71.20% 29.88%
Revenue growth, 5-year CAGR — — 9.75%
Net income growth, 5-year CAGR — 0.00% 0.00%

Health

Metric NMRA OKUR Biotechnology median
Debt to equity 1.19 0.00 0.00
Current ratio 4.50 26.75 4.89
Net debt to EBITDA 0.53 0.95 1.01

Dividend

Metric NMRA OKUR Biotechnology median
Dividend yield — — 0.41%
Payout ratio — — —

Size

Metric NMRA OKUR Biotechnology median
Market cap 91.51m 102.26m 172.11m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack